HomeCompareHOLX vs ADI

HOLX vs ADI: Dividend Comparison 2026

HOLX yields 2.65% · ADI yields 1.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADI wins by $122.1K in total portfolio value· pulled ahead in Year 2
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
ADI
ADI
● Live price
1.34%
Share price
$303.10
Annual div
$4.07
5Y div CAGR
61.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$145.7K
Annual income
$66,714.92
Full ADI calculator →

Portfolio growth — HOLX vs ADI

📍 ADI pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXADI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + ADI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
ADI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
ADI
Annual income on $10K today (after 15% tax)
$114.14/yr
After 10yr DRIP, annual income (after tax)
$56,707.68/yr
At 15% tax rate, ADI beats the other by $56,440.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + ADI for your $10,000?

HOLX: 50%ADI: 50%
100% ADI50/50100% HOLX
Portfolio after 10yr
$84.7K
Annual income
$33,514.47/yr
Blended yield
39.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADI right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
ADI
Analyst Ratings
43
Buy
11
Hold
Consensus: Buy
Price Target
$374.42
+23.5% upside vs current
Range: $270.00 — $430.00
Altman Z
7.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
ADI buys
0
No recent congressional trades found for HOLX or ADI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXADI
Forward yield2.65%1.34%
Annual dividend / share$2.00$4.07
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%61.9%
Portfolio after 10y$23.6K$145.7K
Annual income after 10y$314.03$66,714.92
Total dividends collected$2.9K$118.1K
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$77.80$374.42

Year-by-year: HOLX vs ADI ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrADI PortfolioADI Income/yrGap
1$10,965$264.73$10,917$217.40+$48.00HOLX
2← crossover$12,004$271.27$12,041$359.12$37.00ADI
3$13,121$277.55$13,483$599.29$362.00ADI
4$14,323$283.54$15,442$1,015.38$1.1KADI
5$15,615$289.27$18,283$1,759.59$2.7KADI
6$17,003$294.73$22,715$3,152.16$5.7KADI
7$18,493$299.93$30,230$5,925.67$11.7KADI
8$20,093$304.87$44,279$11,932.68$24.2KADI
9$21,809$309.57$73,824$26,445.87$52.0KADI
10$23,649$314.03$145,707$66,714.92$122.1KADI

HOLX vs ADI: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

ADITechnology

Analog Devices, Inc. designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystems that leverage analog, mixed-signal, and digital signal processing technologies. The company provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and high-end consumer markets; and power ICs include performance, integration, and software design simulation tools for accurate power supply designs. It also offers high-performance amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and microelectromechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators. In addition, the company offers digital signal processing and system products for high-speed numeric calculations. It serves clients in the industrial, automotive, consumer, instrumentation, aerospace, and communications markets through a direct sales force, third-party distributors, and independent sales representatives in the United States, the rest of North and South America, Europe, Japan, China, and rest of Asia, as well as through its Website. Analog Devices, Inc. was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.

Full ADI Calculator →
📬

Get this HOLX vs ADI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.